Related Experiment Video
Updated: Jun 23, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Insights
Primary biliary cirrhosis presents differently in men and women, with men experiencing less pruritus and skin pigmentation. While survival is similar, men have a higher risk of developing hepatoma.
Area of Science:
- Hepatology
- Gastroenterology
- Clinical Medicine
Background:
- Primary biliary cirrhosis (PBC) is a chronic liver disease.
- Understanding sex-based differences in PBC presentation and progression is crucial for patient management.
Purpose of the Study:
- To investigate the differences in presenting features and clinical course of primary biliary cirrhosis between men and women.
- To explore potential factors contributing to observed sex-based variations in PBC.
Main Methods:
- Retrospective review of 39 men and 191 women diagnosed with primary biliary cirrhosis between 1970 and 1984.
- Comparison of demographic data, presenting symptoms (pruritus, skin pigmentation), associated autoimmune conditions, and clinical outcomes (survival, hepatoma development) between sexes.
Main Results:
- Age and disease severity at diagnosis were similar in both sexes.
- Pruritus was significantly less common in men than women (p < 0.01), particularly compared to premenopausal women.
- Skin pigmentation was less marked in men at diagnosis (p < 0.05).
- Autoimmune conditions, such as sicca syndrome, were more prevalent in women.
- Hepatoma developed significantly more frequently in male patients (p < 0.01), while overall survival was similar.
Conclusions:
- Primary biliary cirrhosis exhibits distinct clinical features in men and women, suggesting a potential role for sex hormones in symptom manifestation.
- Men with PBC have a higher risk of developing hepatoma compared to women.
- Further research into sex-specific pathomechanisms and risk factors for PBC complications is warranted.
Abstract:
To determine whether primary biliary cirrhosis differed in men and women we reviewed the presenting features and clinical course of 39 men and 191 women with primary biliary cirrhosis followed at this unit between 1970 and 1984. Age and severity of disease at time of diagnosis were similar in both groups. Pruritus was significantly less common in men than in women both at diagnosis and throughout the period of follow up (p less than 0.01). The difference in incidence of pruritus at diagnosis was most evident when the male group were compared with a group of premenopausal women, an observation which is consistent with involvement of sex steroid metabolism in the origin of pruritus. Skin pigmentation was also less marked in men at diagnosis (p less than 0.05). Autoimmune associated conditions, especially sicca syndrome, were more common in women. Survival was similar among men and women although hepatoma developed significantly more frequently in male patients (p less than 0.01).
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Cirrhosis I: Introduction
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology

